Q1 met expectations, but the guidance downgrade was a surprise
08/05/25 -"Demant’s Q1 results met market expectations. Growth in Hearing Care was counterbalanced by weakness in Hearing Aids. Meanwhile, Diagnostics remained stable. However, profitability fell short of ..."
Pages
61
Language
English
Published on
08/05/25
You may also be interested by these reports :
22/10/25
Sartorius delivered a robust Q3 2025 performance, beating consensus on both revenue and EBITDA, though slightly missing our EBITDA estimate. Revenue ...
20/10/25
“Only when the tide goes out do you discover who’s been swimming naked.” This famous line from Warren Buffett fits well for the ...
20/10/25
Despite a significant downgrade in our estimates, our strong buy recommendation for Elekta remains unchanged. This is supported by ongoing ...
17/10/25
This quarter was strong, driven by the launch of new AI products. We were surprised by the very strong performance in North America and Europe. ...